Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Circulation Research|July 22, 2006
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile functionJohn M Seubert, Christopher J Sinal, Joan Graves, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
The Pharmacogenomics Journal|February 12, 2020
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world dataNita A Limdi, Larisa H Cavallari, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2014
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2Jennifer Cheng, Matthew L Edin, Samantha L Hoopes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2010
Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in miceCraig R Lee, John D Imig, Matthew L Edin, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
Clinical Pharmacology and Therapeutics|July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker TherapyJulio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Circulation Research|July 22, 2006
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile functionJohn M Seubert, Christopher J Sinal, Joan Graves, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
The Pharmacogenomics Journal|February 12, 2020
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world dataNita A Limdi, Larisa H Cavallari, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2014
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2Jennifer Cheng, Matthew L Edin, Samantha L Hoopes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2010
Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in miceCraig R Lee, John D Imig, Matthew L Edin, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
Clinical Pharmacology and Therapeutics|July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker TherapyJulio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Pageof 13